NTA-13

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameNTA-13

Drug Alias Namerenin inhibitors (Nuevolution)NTA-13

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionRenin inhibitors

TargetsRenin

Therapy Area/IndicationsHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNuevolution AS

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNuevolution AS

Active IndicationsN/A

Inactive IndicationsHypertension

ATC CodeN/A